Trial intelligence / Profile preview

Modafinil after coronary artery bypass graft surgery

IRCT20200611047728N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in coronary arteriosclerosis comparing Modafinil with Placebo (2 arms). Primary endpoints: Duration of hospital stay, Results and quality of life and 1 more. Started Jun 2020; status: completed.

02

Drugs

modafinil
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT20200611047728N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200611047728N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call